RxDoctor Payments Data

Rabeya Nazer

Family · Jacksonville, FLNPI 1275255226

Payments from drug & device makers

$1,479in general payments, 2019–2025

Across 79 payments — averaging $18.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$272
  • Amgen$255
  • Novo Nordisk$199
  • AbbVie$169
  • Boehringer Ingelheim$105
  • Dexcom, Inc.$104
  • plus $375 from 10 others

What the payments were for

  • Food & beverage$1,479100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,479 in reported general payments places this provider in the 75th percentile of 14,618 family providers in Florida.

See all family providers in Florida

Medicare billing

Part B allowed, 2024
$14,773
Medicare patients
123
Services billed
209

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fluticasone Propionate37$601
Prednisone58$115
Cephalexin17$85
Azithromycin21$77

Paid to pharmacies, not to this prescriber.

Other family in Jacksonville

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →